Evidence-based guidelines for treating bipolar disorder

2704560472_63b23c8c4e_b

Joseph Hayes summarises the recent British Association for Psychopharmacology guidelines for the treatment of bipolar disorder, and compares their recommendations with those found in the NICE bipolar disorder guidance from 2014.

[read the full story...]

Antidepressants for depression: new BAP guidance

shutterstock_103021367

Helge Hasselmann summarises the recently published evidence-based guidance on antidepressants for depression published by the British Association for Psychopharmacology.

[read the full story...]

Updated substance misuse guidelines from the British Association for Psychopharmacology

shutterstock_52270387

Psychiatrists, GPs and other professionals working in the substance misuse field will benefit from reading these new guidelines from the British Association for Psychopharmacology. The guidelines cover the pharmacological management of alcohol, nicotine, opioids, benzodiazepines, stimulants and associated comorbidity with mental health problems and substance use or abuse in pregnancy. They look specifically at comorbidity, [read the full story…]

New consensus guidelines on the pharmacological treatment of schizophrenia

shutterstock_11411980 consensus

The British Association for Psychopharmacology regularly publish consensus guidelines on the pharmacological treatment of mental health conditions. In the last two years these publications have included guidance on insomnia (PDF), dementia (PDF) and bipolar disorder (PDF). The latest guideline from the BAP is on the pharmacological treatment of schizophrenia and as usual it’s available in full-text [read the full story…]